Cancer - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Last Posted: Jul-08-2019 10:55:06

What's New

Last Posted: Jul 05, 2019

---

• Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction  
  DM Kurtz et al, Cell, July 4, 2019
• BRAF Gene Copy Number and Mutant Allele Frequency Correlate with Time to Progression in Metastatic Melanoma Patients Treated with MAPK Inhibitors.  
  Stagni Camilla et al. Molecular cancer therapeutics 2018 17(6) 1332-1340
• Background, current role, and potential applications of radiogenomics.  
  Pinker Katja et al. Journal of magnetic resonance imaging : JMRI 2018 47(3) 604-620
• BRAF Adds an Additional Piece of the Puzzle to Precision Oncology-Based Treatment Strategies in Lung Cancer.  
  Planchard David et al. Archives of pathology & laboratory medicine 2018 142(7) 796-797
• Clinical Cancer Genetics in a Lower-Middle Income Country: Considerations for Policymaking.  
  Ginsburg Ophira et al. Journal of global oncology 2018 41-3
• Clinical outcomes of patients with resected, early-stage ALK-positive lung cancer.  
  Chaft Jamie E et al. Lung cancer (Amsterdam, Netherlands) 2018 12267-71
• EGFR Mutational Profiling in Non-Small Cell Lung Cancer: The Clinical Performance of a Sensitive Reverse-Hybridization Assay.  
  Kriegshäuser Gernot et al. Applied immunohistochemistry & molecular morphology : AIMM 2018 Jul 26(6) 388-392
• Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis.  
  Duruisseaux Michäel et al. The Lancet. Respiratory medicine 2018 6(10) 771-781
• First-line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non-Small-cell Lung Cancer With Different Prognostic Significance.  
  Iams Wade T et al. Clinical lung cancer 2018 19(6) 531-543
• Impacts of EGFR-mutation status and EGFR-TKI on the efficacy of stereotactic radiosurgery for brain metastases from non-small cell lung adenocarcinoma: A retrospective analysis of 133 consecutive patients.  
  Yomo Shoji et al. Lung cancer (Amsterdam, Netherlands) 2018 119120-126
• Is There a Duty to Warn Parents of a Cancer-Causing Genetic Mutation?  
  Tarzian Anita J et al. The American journal of bioethics : AJOB 2018 Jul 18(7) 73-74
• Liquid biopsy of fine-needle aspiration supernatant for lung cancer genotyping.  
  Guibert Nicolas et al. Lung cancer (Amsterdam, Netherlands) 2018 12272-75
• microRNA expression pattern as an ancillary prognostic signature for radiotherapy. 
  Li An-Lun et al. Journal of translational medicine 2018 16(1) 341
• Rare germline copy number variants in colorectal cancer predisposition characterized by exome sequencing analysis.  
  Franch-Expósito Sebastià et al. Journal of genetics and genomics = Yi chuan xue bao 2018 45(1) 41-45
• Symptoms and Health-Related Quality of Life in Patients Receiving Cancer Therapy Matched to Genomic Profiles.  
  Williams Kirstin et al. Oncology nursing forum 2018 45(6) E125-E136